CINECA IRIS Institutional Research Information System

VERSINO, Elisabetta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.431
EU - Europa 4.091
AS - Asia 1.525
AF - Africa 56
OC - Oceania 51
SA - Sud America 40
Continente sconosciuto - Info sul continente non disponibili 15
Totale 11.209
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.278
IT - Italia 1.331
CN - Cina 620
IE - Irlanda 430
SG - Singapore 424
DE - Germania 402
FR - Francia 367
UA - Ucraina 306
SE - Svezia 300
FI - Finlandia 265
GB - Regno Unito 216
KR - Corea 198
CA - Canada 131
PL - Polonia 104
DK - Danimarca 80
VN - Vietnam 75
AT - Austria 58
IN - India 58
AU - Australia 46
NL - Olanda 45
ES - Italia 43
ID - Indonesia 35
BE - Belgio 34
SN - Senegal 23
CH - Svizzera 20
RU - Federazione Russa 20
BR - Brasile 18
MX - Messico 18
MY - Malesia 18
EU - Europa 15
JP - Giappone 15
IR - Iran 14
TW - Taiwan 14
HK - Hong Kong 11
RO - Romania 11
MU - Mauritius 10
GR - Grecia 9
PH - Filippine 9
CO - Colombia 8
NO - Norvegia 8
TH - Thailandia 8
TR - Turchia 8
ZA - Sudafrica 8
CZ - Repubblica Ceca 7
PT - Portogallo 7
AR - Argentina 5
EC - Ecuador 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
SK - Slovacchia (Repubblica Slovacca) 5
SM - San Marino 5
BY - Bielorussia 4
HR - Croazia 4
CY - Cipro 3
EG - Egitto 3
ET - Etiopia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
EE - Estonia 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
MK - Macedonia 2
PE - Perù 2
SA - Arabia Saudita 2
AL - Albania 1
AN - Antille olandesi 1
DZ - Algeria 1
GT - Guatemala 1
IS - Islanda 1
KW - Kuwait 1
LK - Sri Lanka 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
PK - Pakistan 1
PR - Porto Rico 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
VC - Saint Vincent e Grenadine 1
Totale 11.209
Salva come PNG Salva come JPEG
Città #
Chandler 558
Houston 504
Beijing 436
Dublin 425
Singapore 348
Ann Arbor 334
Santa Clara 329
Dearborn 203
Fairfield 201
Torino 191
Jacksonville 183
Villeurbanne 167
Ashburn 161
Wilmington 159
Medford 149
Princeton 144
Woodbridge 132
Columbus 118
Nyköping 110
Milan 101
Warsaw 97
Seattle 94
Pisa 57
Boston 56
Rome 56
Vienna 54
Redwood City 52
Turin 48
Cambridge 46
Verona 39
Dong Ket 35
Fremont 33
Falls Church 25
Guangzhou 25
Vancouver 24
Boardman 23
Jakarta 23
Bologna 20
Lachine 20
Washington 19
Brussels 18
Norwalk 18
Hefei 17
Munich 16
San Diego 16
Padova 14
Bari 13
Helsinki 13
London 13
Nanjing 13
Toronto 13
Florence 12
Pune 12
Montréal 11
New York 11
Brisbane 9
Nanchang 9
Naples 9
Antioch 8
Appiano Gentile 8
Chicago 8
Fuzhou 8
Los Angeles 8
Chengdu 7
Hanoi 7
Ivrea 7
Kunming 7
Paris 7
Phoenix 7
Redmond 7
Rio Saliceto 7
San Mateo 7
Udine 7
Viggiano 7
Amsterdam 6
Barcelona 6
Catania 6
Citta 6
Dallas 6
Hebei 6
Mountain View 6
Ottawa 6
Palermo 6
Shanghai 6
Sheffield 6
Silver Spring 6
Taipei 6
Tokyo 6
Buffalo 5
Central District 5
Coral Gables 5
Des Moines 5
Hangzhou 5
Mexico 5
Napoli 5
Nürnberg 5
Pelham 5
Piacenza 5
Prague 5
Quito 5
Totale 6.297
Salva come PNG Salva come JPEG
Nome #
Methadone maintenance at different dosages for opioid dependence (Review) 683
Il fenomeno delle dipendenze nella donna: aspetti epidemiologici, biologici, socio-ambientali, clinici, comportamentali 471
Universal school-based prevention for illicit drug use 448
Vegan-vegetarian low-protein supplemented diets in pregnant CKD patients: Fifteen years of experience 365
The effectiveness of school-based interventions in preventing illicit drugs’ use 279
Does substance use disorder affect clinical expression in first-hospitalization patients with schizophrenia? Analysis of a prospective cohort 260
School-based prevention for illicit drugs' use (Review) 258
Compulsory Psychiatric Admissions in an Italian Urban Setting: Are They Actually Compliant to the Need for Treatment Criteria or Arranged for Dangerous Not Clinical Condition?. 256
Le differenze di genere nella tossicodipendenza da eroina 251
Inappropriate proton pump inhibitor prescription in elderly adults: as usual as dangerous. 244
Type D personality and essential hypertension in primary care. a cross-sectional observational study within a cohort of patients visiting general practitioners. 211
Proton pump inhibitors and hypomagnesemia in polymorbid elderly adults 201
Low-protein diets in diabetic chronic kidney disease (CKD) patients: Are they feasible and worth the effort? 165
Risk factors for primary open angle glaucoma (POAG) progression: A study ruled in Torino 163
Tuberculosis incidence in Turin, Italy, 1973-1999 161
Gender differences in heroin addiction and treatment: results from the VEdeTTE cohort 147
Diet as a system: an observational study investigating a multi-choice system of moderately restricted low-protein diets 132
L'efficacia degli interventi scolastici per la prevenzione dell'uso di sostanze illegali:una revisione Cochrane 129
Risultati della revisione Cochrane sull’efficacia degli interventi di prevenzione primaria dell’uso di sostanze illecite effettuati nelle scuole 129
A follow-up study of heroin addicts (VEdeTTE2): study design and protocol 119
A Systematic Review on Materno-Foetal Outcomes in Pregnant Women with IgA Nephropathy: A Case of "Late-Maternal" Preeclampsia? 117
Treatment response to interferon beta: Biological (MxA protein or IL-10 mRNA level) or MRI indicators? 114
Patient survival and costs on moderately restricted low-protein diets in advanced CKD: Equivalent survival at lower costs? 110
Differenze di genere alla presa in carico al SerT: risultati dallo studio VEdeTTE 107
Differenze di genere nella dipendenza: evidenze epidemiologiche 103
A 4-year multicenter follow-up of neutralizing anti-interferon antibodies in ms patients treated with high dose (375 mcg) interferon beta-1b 102
Pregnancy in dialysis patients in the new millennium: a systematic review and meta-regression analysis correlating dialysis schedules and pregnancy outcomes 102
MONTAGNA E SALUTE: UNO SVANTAGGIO SOLO GEOGRAFICO O LEGATO ANCHE ALLA MIGRAZIONE SELETTIVA? 100
EFFICACIA DI UN VIDEO INFORMATIVO NELLA RIDUZIONE DEL LIVELLO DI ANSIA INPAZIENTI SOTTOPOSTI A CORONAROGRAFIA ELETTIVA: UNO STUDIO RCT 97
Which low-protein diet for which CKD patient? An observational, personalized approach 96
Pre-eclampsia or chronic kidney disease? The flow hypothesis. 93
The OPTimization of Interferon for MS Study: 375 μg interferon beta-1b in suboptimal responders 90
Deaths attributable to tobacco smoking in Italy 90
Type 2 diabetes mellitus and chronic hepatitis C: Which is worse? Results of a long-term retrospective cohort study. 89
SURVIVAL ON LOW-PROTEIN DIETS: RESULTS OF A MULTIPLE CHOICE APPROACH 89
Is the combination of different treatment responseindicators useful to identify patients with a sub-optimal response to interferon beta? 86
Clinical and laboratory tolerability evaluation of treatment with high-dose interferon beta-1b (500mcg every-other-day, subcutaneously) in ms patients. 85
Cytokines and Chemokine mRNA in perpheral blood of multiple sclerosis patients correlates with treatment response and interferon beta dose 84
L'igiene tra passato glorioso e incerto futuro: riflessioni 83
Clinically isolated syndrome: when to treat? A Cochrane analysis 82
Moderate protein restriction in advanced CKD: A feasible option in an elderly, high-comorbidity population. a stepwise multiple-choice system approach 82
Correlation of anti-interferon beta neutralising antobodies with clinical response and mri activity in the INCOMIN (independent comparison of interferon) trial. 81
[Determinants of social inequalities in health in Italy] 80
Gli interventi educativi in a mb i t o scolastico nella prevenzione dell'uso di sostanze illecite: una revisione Cochrane per valurarne l'efficacia 79
Decennial trends of social differentials in smoking habits in Italy 76
Interventi in setting scolastico per la prevenzione dell'uso di sostanze illegali 74
Treatment response indicators in multiple sclerosis. Persistence of mri activity during first months of immune-modulating drug treatment is predictive of persistence of clinical disease activity over the long term 72
Assessing treatment response to immunomodulatory drugs for ms: a single active mri scan after 6 months of treatment is the best indicator of persisting disease activity 72
Comparision of a biological (mxa protein level) and an mri treatment response indicator for interferon beta therapy in multiple sclerosis 69
Gender health and policies: the state of the art from exposure to solutions 68
Differenze regionali nella mortalità da Overdose e possibili spiegazioni 67
A systematic review and meta-analysis indicates long-term risk of chronic and end-stage kidney disease after preeclampsia. 66
Methadone maintenance at different dosages for opioid dependence 65
Immunomodulatory agents in Multiple Sclerosis: clinical trials and therapy 65
Studio VEdeTTE – Monografia n° 7 – Differenze di genere nello studio VEdeTTE. Studio VEdeTTE 65
Tobacco smoke in Piedmont: attributable morbidity and impact on hospital costs 65
COVID-19 Vaccine Hesitancy in Patients on Dialysis in Italy and France 65
Reflux nephropathy and the risk of preeclampsia and of other adverse pregnancy-related outcomes: a systematic review and meta-analysis of case series and reports in the new millennium 64
I determinanti delle disuguaglianze sociali nella salute in Italia 63
Best indicator of persisting disease activity 62
Using biological (mxa protein or il-10 mrna level) or mri indicators for assessing treatment response to interferon-beta 62
Consumo di ecstasy tra i diciottenni della Regione Piemonte convocati per la visita di leva 62
Tuberculosis incidence in Turin, Italy: 1973-1999 61
VEdeTTE – studio di valutazione dell’efficacia dei trattamenti per la tossicodipendenza da eroina. Monografia n°4 – Analisi descrittiva della coorte arruolata nei primi 18 mesi dello studio 59
School-based prevention for illicit drugs use: a systematic review 59
The effectiveness of school-based interventions in preventing illicit drug use 58
Neutralizing antibodies in multiple sclerosis patients treated with 375 μg interferon-β-1b 58
Maternal-foetal outcomes in pregnant women with glomerulonephritides. Are all glomerulonephritides alike in pregnancy? 58
Chronic kidney disease: The complex history of the organization of long-term care and bioethics. why now, more than ever, action is needed 58
Tobacco attributable morbidity and hospital costs in Piedmont: forecast for the years 2003-2014 57
Differenze di genere: evidenze dallo studio VEdeTTE 57
Mxa protein and interleukin-10 (il-10) leukocyte production and anti-ifn neutralizing antibody(nab) occurrence in relapsing remitting multiple sclerosis (rrms) patients treated with different doses of interferon (ifn) beta- 1b 55
Every-other-day interferon beta-1b compared with once weekly interferon beta 1-a in ms. further analysis of treatment effect on mri activity and neutralizing antibodies (nabs) in the INCOMIN trial 54
Esperienze e sviluppi dei registri e sorveglianze in Italia: un progetto ad hoc. 54
The independent comparison of interferon (incomin) trial: correlation of neutralising antibodies anti-interferon beta with clinical response and mri activity 53
Influence of posterior vitreous detachment and type of intraocular lens on lipid peroxidation in the human vitreous. 53
Mxa protein in ms patients treated with different doses of ifn beta-1b (the optims study): correlation with treatment response, ifn beta dose, and neutralizing antibodies (nab)occurrence 52
NAB titre in patients treated with different doses of ifn beta-1b: preliminary results from the optims study. 51
Methadone treatment in clinical practice in Italy: need for improvement 51
Interferon-beta-1b in multiple sclerosis: comparing two different doses (the OPTIMS Study) 51
Management of multiple sclerosis patients after the 24th Natalizumab course: the Ty-STOP study 51
Pregnancy outcomes after kidney graft in Italy: are the changes over time the result of different therapies or of different policies? A nationwide survey (1978-2013). 51
The best indication to early treat the clinically isolated syndrome based on the clinical onset. A Cochrane analysis 50
Fatti e cifre sul fumo di tabacco; Piemonte 2005 49
Metadone maintenance (MMT) at different dosages for opioid dependence: a Cochrane review 49
Prospettiva di medicina interna sui fattori di rischio della progressione del glaucoma primario ad angolo aperto: uno studio effettuato a Torino 48
Gender differences in heroin addiction: results from the VEdeTTE cohort 47
Letters to the Editor 47
Studio VEdeTTE. Monografia numero 7. Differenze di genere nello studio VEdeTTE 47
Increasing dose of ifn beta 1b in ms patients: preliminary nab results from the optims study. 46
The optims study. I looking for a treatment response marker 45
The optims trial: the first prospective long term predictivity analysis trial of a treatment response marker to immunomodulatory drug in ms. 45
School based prevention for illicit drugs’ use (Systematic review ) 45
Tossicodipendenza da eroina e valutazione d’efficacia degli interventi:lo studio VEdeTTE 45
IFN beta-1b 500 mcg every-other-day, subcutaneously in MS patients. Tolerability, clinical and MRI results after one year of treatment 45
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN). 45
Frequenza e durata dell’allattamento al seno nella Provincia di Benevento, 1999. Ricerca in pediatria ambulatoriale 44
Every-other-day interferon beta-1b compared with once-weekly interferon beta-1a in MS. Further analysis of treatment effect on MR1 activity and neutralising antibodies (NAbs) in the INCOMIN Trial 44
IFN beta-1b in multiple sclerosis: comparing two different doses (the Optims Study). 43
Interferon beta-1b 500 mcg every-other-day, subcutaneously in ms patients. Tolerability, clinical and mri results after one year of treatment 43
Totale 10.443
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.359
article - articoli 0
book - libri 0
conference - conferenze 11.609
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.968
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.272 0 0 0 0 0 496 194 98 160 152 99 73
2020/20211.120 128 56 120 44 74 45 66 45 230 100 60 152
2021/20221.299 56 39 49 125 69 67 84 85 64 76 210 375
2022/20231.765 228 134 84 140 154 486 147 106 133 40 66 47
2023/2024795 74 123 38 64 50 72 29 27 14 49 88 167
2024/20251.219 48 233 81 221 517 119 0 0 0 0 0 0
Totale 11.670